KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Inventory Average (2016 - 2026)

AbbVie has reported Inventory Average over the past 13 years, most recently at $4.9 billion for Q4 2025.

  • Quarterly Inventory Average rose 14.58% to $4.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 billion through Dec 2025, up 14.58% year-over-year, with the annual reading at $4.6 billion for FY2025, 10.29% up from the prior year.
  • Inventory Average was $4.9 billion for Q4 2025 at AbbVie, roughly flat from $4.9 billion in the prior quarter.
  • Over five years, Inventory Average peaked at $4.9 billion in Q3 2025 and troughed at $3.1 billion in Q4 2021.
  • The 5-year median for Inventory Average is $4.0 billion (2023), against an average of $3.9 billion.
  • The largest YoY upside for Inventory Average was 79.98% in 2021 against a maximum downside of 13.98% in 2021.
  • A 5-year view of Inventory Average shows it stood at $3.1 billion in 2021, then rose by 8.5% to $3.4 billion in 2022, then rose by 19.69% to $4.0 billion in 2023, then rose by 6.82% to $4.3 billion in 2024, then increased by 14.58% to $4.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Inventory Average are $4.9 billion (Q4 2025), $4.9 billion (Q3 2025), and $4.7 billion (Q2 2025).